Sabarathinam Sarvesh (Sarvesh Sabarathinam)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 19

Top Topics

Mycobacterium Tuberculosis

Molecular Docking

Top Venues

Future science OA

Health science reports

Future medicinal chemistry

Natural product research

This page only lists publications with an associated author ORCID identifier.

Publications

Sabarathinam Sarvesh, Sanjana Satheesh, Arun Raja
A computer-aided insight into the identification of significant therapeutic flavone as a promising agent for sarcopenic obesity. Natural product research (2023)
Sabarathinam Sarvesh, Sanjana Satheesh, Rajappan Chandra Satish Kumar
Physicochemical investigation and molecular docking analysis of Maha yogaraj Guggulu tablet and virtual screening of its major bioactive compound. Natural product research (2023)
Chinnaperumal Kamaraj, Rajappan Chandra Satish Kumar, Khalid A Al-Ghanim, Marcello Nicoletti, V Sathiyamoorthy, Sabarathinam Sarvesh, Chinnasamy Ragavendran, Marimuthu Govindarajan
Novel Essential Oils Blend as a Repellent and Toxic Agent against Disease-Transmitting Mosquitoes. Toxics 11 (6) (2023)
Sabarathinam Sarvesh, Nila Ganamurali
Chalcones reloaded: an integration of network pharmacology and molecular docking for type 2 diabetes therapy. Journal of biomolecular structure & dynamics (2023)
Pradeepti Ganesh, Vanishree Suresh, Manoj Kumar Narasimhan, Sabarathinam Sarvesh
A narrative review on Naringin and Naringenin as a possible bioenhancer in various drug-delivery formulations. Therapeutic delivery (2023)
Sabarathinam Sarvesh
A glycemic diet improves the understanding of glycemic control in diabetes patients during their follow-up. Future science OA 9 (3) (2023)
Sabarathinam Sarvesh, Satish Kumar Rajappan Chandra, Sanjana Satheesh
Network pharmacology based pharmacokinetic assessment and evaluation of the therapeutic potential of catechin derivatives as a potential myostatin inhibitor: A special view on Sarcopenic Obesity. Natural product research (2023)
Sabarathinam Sarvesh, Nila Ganamurali, Sanjana Satheesh, Dhivya Dhanasekaran, Arun Raja
Pharmacokinetic correlation of structurally modified chalcone derivatives as promising leads to treat tuberculosis. Future medicinal chemistry (2023)
Prerna Khagar, Atul V Wankhade, Sabarathinam Sarvesh
Synthesis of quercetin-iron (Fe) complex and its in silico and in vitro confirmation towards antibacterial activity. Future medicinal chemistry (2023)
Sabarathinam Sarvesh, Dhivya Dhanasekaran, Nila Ganamurali
Artificial sweetener is a growing threat for metabolic syndrome: why is extra attention required? Future science OA 9 (8) (2023)
Chinnaperumal Kamaraj, Rajappan Chandra Satish Kumar, Khalid A Al-Ghanim, Marcello Nicoletti, V Sathiyamoorthy, Sabarathinam Sarvesh, Chinnasamy Ragavendran, Marimuthu Govindarajan
Novel Essential Oils Blend as a Repellent and Toxic Agent against Disease-Transmitting Mosquitoes. Toxics 11 (6) (2023)
Priya Sivasakthi, Sabarathinam Sarvesh, Thangavel Mahalingam Vijayakumar
Network pharmacology and in silico pharmacokinetic prediction of Ozanimod in the management of ulcerative colitis: A computational study. Health science reports 5 (1) (2022)
Mariyappan Vaithiyalingam, Dhivya Loganathan Sumathi, Sabarathinam Sarvesh
Isolation and In silico Study of Curcumin from Curcuma longa and Its Anti-Diabetic Activity. Applied biochemistry and biotechnology (2022)
Loganathan Sumathi Dhivya, Balappaudayar R Pradeepa, Sabarathinam Sarvesh
Synthesis and in vitro studies for structure-based design of novel chalcones as antitubercular agents targeting InhA . Future medicinal chemistry 14 (12) (2022)
Lakshminarayanan Preethi, Alina Mylanikunathil Saji, Lakshmi Chandran, Asvin Suresh, Sambasivam Indra, Sabarathinam Sarvesh
Pandemic-induced stress and obesity leading to abnormal uterine bleeding: A prospective study. Health science reports 5 (2) (2022)
Anuba Paulvarnan Anitha, Swetha Balasubramanian, Arun Gopal Ramalingam, Shini Rubina Samuel Kennady, Nila Ganamurali, Dhivya Dhanasekaran, Sabarathinam Sarvesh
An exploration of the experience of dapagliflozin in clinical practice. Future science OA 8 (8) (2022)
Loganathan Sumathi Dhivya, Sabarathinam Sarvesh, Ankul Singh S
Inhibition of Mycobacterium tuberculosis InhA (Enoyl-acyl carrier protein reductase) by synthetic Chalcones: a molecular modelling analysis and in-vitro evidence. Journal of biomolecular structure & dynamics (2022)
Sk Sujitha Priya, Ankita Jha, Rajappan Chandra Satish Kumar, Sabarathinam Sarvesh
The role of guggulsterone on the NF-κB pathway in inflammatory bowel disease: preclinical evidence. Future science OA 8 (6) (2022)
Asvitha Govindaraju, Sabarathinam Sarvesh
Bempedoic acid: A nonstatin drug for the management of hypercholesterolemia. Health science reports 4 (4) (2021)